Latest & greatest articles for amphetamine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amphetamine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amphetamine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amphetamine

1. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis

Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis Clinical guidelines recommend psychosocial interventions for cocaine and/or amphetamine addiction as first-line treatment, but it is still unclear which intervention, if any, should be offered first. We aimed to estimate the comparative effectiveness of all available psychosocial interventions (alone or in combination (...) ) for the short- and long-term treatment of people with cocaine and/or amphetamine addiction.We searched published and unpublished randomised controlled trials (RCTs) comparing any structured psychosocial intervention against an active control or treatment as usual (TAU) for the treatment of cocaine and/or amphetamine addiction in adults. Primary outcome measures were efficacy (proportion of patients in abstinence, assessed by urinalysis) and acceptability (proportion of patients who dropped out due to any

Full Text available with Trip Pro

2019 EvidenceUpdates

2. Amphetamines probably the best first-choice treatment for adults with ADHD

Amphetamines probably the best first-choice treatment for adults with ADHD Amphetamines probably the best first-choice treatment for adults with ADHD Discover Portal Discover Portal Amphetamines probably the best first-choice treatment for adults with ADHD Published on 30 October 2018 doi: There is further evidence to support the amphetamines as the most effective group of drugs for treating adults with attention deficit hyperactivity disorder in the short-term. Two of these drugs were shown (...) to provide the most improvement in core symptoms of attention deficit hyperactivity disorder, are tolerated as well as any other drug treatment and are less likely to be stopped. The review did not identify data to determine whether amphetamines should continue to be used for longer than 12 weeks. This large, comprehensive NIHR-funded systematic review included published and unpublished randomised controlled trials of different drug treatments. The quality of the included trials was mixed, with only

2019 NIHR Dissemination Centre

3. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. (PubMed)

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of mental and physical symptoms including anxiety, confusion, insomnia, mood disturbances, cognitive impairments, paranoia, hallucinations and delusion.Currently

2018 Cochrane

4. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. (PubMed)

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterised by inattention, hyperactivity, and impulsivity. ADHD can persist into adulthood and can affects individuals' social and occupational functioning, as well as their quality of life and health. ADHD is frequently associated with other mental disorders such as substance use disorders and anxiety and affective disorders. Amphetamines (...) are used to treat adults with ADHD, but uncertainties about their efficacy and safety remain.To examine the efficacy and safety of amphetamines for adults with ADHD.In August 2017, we searched CENTRAL, MEDLINE, Embase, PsycINFO, 10 other databases, and two trials registers, and we ran citation searches for included studies. We also contacted the corresponding authors of all included studies, other experts in the field, and the pharmaceutical company, Shire, and we searched the reference lists

2018 Cochrane

5. Amphetamine

Amphetamine Top results for amphetamine - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for amphetamine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

7. The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis

The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis "The Use of Amphetamines for Improving Cognitive Impairment in Patients" by Hayley Kum < > > > > > Title Author Date of Graduation Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Elizabeth Crawford, PA-C, MS Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: Multiple sclerosis (MS) is an autoimmune disorder (...) that results in debilitating cognitive impairment in 40-65% of patients. There are no current treatments for this symptom of MS. This is a systematic review of literature on the impact amphetamines have on cognitive function of MS patients. Methods: An exhaustive search of available medical literature was conducted using MEDLINE-Ovid, MEDLINE-PubMed, Web of Science, and CINAHL. Keywords used included: amphetamines and multiple sclerosis. Relevant articles were assessed for quality using GRADE. Results

2016 Pacific University EBM Capstone Project

8. No evidence of benefit of psychostimulants for amphetamine abuse or dependence

No evidence of benefit of psychostimulants for amphetamine abuse or dependence No evidence of benefit of psychostimulants for amphetamine abuse or dependence | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms No evidence of benefit of psychostimulants for amphetamine abuse or dependence Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS

9. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. (PubMed)

Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Amphetamine dependence is a public health problem with medical, psychiatric, cognitive, legal and socioeconomic consequences. To date, no pharmacological treatment has been approved for this disorder, and psychotherapy remains the mainstay of treatment. In recent years, psychostimulants have been investigated as a possible replacement therapy.To evaluate the efficacy and safety of psychostimulant medications for amphetamine (...) lists of retrieved trials, the list of studies citing the included trials and the main electronic registers of ongoing trials (ClinicalTrials.gov, International Clinical Trials Registry Platform and EU Clinical Trials Register). Finally, we contacted investigators to request information about unpublished trials. Searches included non-English language literature.All randomised, placebo-controlled, parallel-group clinical trials investigating the efficacy or safety of psychostimulants for amphetamine

Full Text available with Trip Pro

2013 Cochrane

10. Clandestine Amphetamine-Derived Drug Laboratories: Remediation Guidelines for Residential Settings

Clandestine Amphetamine-Derived Drug Laboratories: Remediation Guidelines for Residential Settings REVISED DECEMBER 2012 1 Clandestine Amphetamine-Derived Drug Laboratories: Remediation Guidelines for Residential Settings Prabjit Barn, Michele Wiens, Patti Dods Summary • Clandestine labs produce illegal substances using a variety of chemicals and manufacturing processes. • Clandestine labs can be housed in a variety of structures, including residential and non-residential buildings (...) . In particular, residential buildings previously used for clandestine labs can pose health concerns to re-occupants. • Amphetamine-derived drug labs are the most common type of clandestine lab found in most provinces. • Here we present guidelines on the remediation of clandestine amphetamine-derived drug labs for the purposes of protecting the health of re-occupants. These guidelines do not address other health hazards that may be encountered during cleanup. a • These guidelines are derived from instructions

2012 National Collaborating Centre for Environmental Health

11. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. (PubMed)

Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Attention Deficit Hyperactivity Disorder (ADHD) is a childhood onset disorder that can persist into adulthood. Amphetamines are used to treat adult ADHD, but uncertainties persist about their efficacy and safety.To examine the efficacy and safety of amphetamines for adults with ADHD, as well as the influence of dose, drug type and release formulation type.We searched CENTRAL, PubMed, EMBASE, CINAHL, PsycINFO (...) , clinicaltrials.gov, UK Clinical Trials Gateway and references obtained from articles and experts in the field. We conducted the electronic searches on 25 February 2010.Randomized controlled trials comparing the efficacy of amphetamine derivatives against placebo or an active intervention.Two authors extracted data from each included study. We used the standardized mean difference (SMD) and the risk ratio (RR) to assess continuous and dichotomous outcomes, respectively. We conducted a stratified analysis

2011 Cochrane

12. Amphetamine-group substances and HIV. (PubMed)

Amphetamine-group substances and HIV. Amphetamine-group substances are used worldwide and are more prevalent than either cocaine or opioids. We reviewed published reports about amphetamine-group substances and did a meta-analysis of randomised controlled trials of behavioural interventions for their use. Most research was done in developed countries. Many, but not all, studies show an association between amphetamine-group substance use and risk of HIV infection. Much use of amphetamine-group (...) substances is non-injection and is associated with increased HIV risk, particularly in men who have sex with men. The structural, social, interpersonal, and personal factors that link to amphetamine-group substance use and HIV risk are poorly understood. 13 studies, with a cumulative sample size of 1997 individuals, qualified for the meta-analysis. Overall, high-intensity behavioural interventions were moderately effective in reducing use of amphetamine-group substances (effect size 0.28, 95% CI 0.13

2010 Lancet

13. Treatment for amphetamine psychosis. (PubMed)

Treatment for amphetamine psychosis. Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.To evaluate risks, benefits, costs of treatments for amphetamine psychosis.MEDLINE (1966-2007), EMBASE (1980-2007), CINAHL (1982-2007), PsychINFO (1806-2007), CENTRAL (Cochrane Library 2008 issue 1), references (...) of obtained articles.All randomised controlled and clinical trials (RCTs, CCTs) evaluating treatments (alone or combined) for people with amphetamine psychosisTwo authors evaluated and extracted the data independently. Dichotomous data were extracted on an intention-to-treat basis in which the dropouts were assigned as participants with the worst outcomes. The Relative Risk (RR) with the 95% confidence interval (95% CI) was used to assess the dichotomous data. The Weighted Mean Difference (WMD) with 95

2009 Cochrane

14. Review: limited evidence to support pharmacological therapy for amphetamine withdrawal

Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Review: limited evidence to support pharmacological therapy for amphetamine withdrawal | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Article Text Therapeutics Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Free Michael

Full Text available with Trip Pro

2009 Evidence-Based Mental Health

15. Treatment for amphetamine psychosis. (PubMed)

Treatment for amphetamine psychosis. Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.To evaluate risks, benefits, costs of treatments for amphetamine psychosis.MEDLINE (1966-2007), EMBASE (1980-2007), CINAHL (1982-2007), PsychINFO (1806-2007), CENTRAL (Cochrane Library 2008 issue 1), references (...) of obtained articles.All randomised controlled and clinical trials (RCTs, CCTs) evaluating treatments (alone or combined) for people with amphetamine psychosisTwo authors evaluated and extracted the data independently. Dichotomous data were extracted on an intention-to-treat basis in which the dropouts were assigned as participants with the worst outcomes. The Relative Risk (RR) with the 95% confidence interval (95% CI) was used to assess the dichotomous data. The Weighted Mean Difference (WMD) with 95

2008 Cochrane

16. What is the risk of AMI in amphetamine induced chest pain presenting to the ED?

What is the risk of AMI in amphetamine induced chest pain presenting to the ED? BestBets: What is the risk of AMI in amphetamine induced chest pain presenting to the ED? What is the risk of AMI in amphetamine induced chest pain presenting to the ED? Report By: Dr Bhavesh Papadi - SHO Medicine Search checked by Dr Karthikeyan Perumal - Radiation oncologist Institution: Chase Farm Hospital Date Submitted: 30th June 2007 Last Modified: 14th August 2008 Status: Green (complete) Three Part Question (...) In [patients presenting with chest pain following amphetamine use] what [is the incidence] of [acute myocardial infarction]? Clinical Scenario You are working in a very busy Accident and Emergency Department and the Triage Nurse informs you that, a patient with "Amphetamine induced chest pain" has just arrived. you wonder , what his chances are, to develop Acute Myocardial Infarction. Search Strategy Ovid MEDLINE(R) 1950 to March Week 2 2008 [exp Amphetamine-Related Disorders/or exp Amphetamine

2008 BestBETS

17. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. (PubMed)

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. The consumption of psychostimulants for non-medical reasons probably occurs because of their euphoriant and psychomotor-stimulating properties. Chronic consumption of these agents results in development of stereotyped behaviour, paranoia, and possibly aggressive behaviour. Psychosocial treatments for psychostimulant use disorder are supposed to improve compliance, and to promote abstinence. Evidence from

2007 Cochrane

18. Amphetamines for improving recovery after stroke. (PubMed)

Amphetamines for improving recovery after stroke. Animal research shows that treatment with amphetamines improves recovery after focal cerebral ischaemia. If the effects are similar in humans, amphetamine treatment could have a major impact on recovery from stroke.To assess the effects of amphetamine treatment in patients with stroke.We searched the Cochrane Stroke Group Trials Register (last searched January 2006), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane (...) Library Issue 1, 2006), MEDLINE (1966 to January 2006), EMBASE (1980 to January 2006), CINAHL (1982 to January 2006), CINAHL (1982 to January 2006), Science Citation Index (1992 to March 2005) and registers of ongoing trials. We also checked the reference lists of all relevant articles and reviews, and contacted researchers in the field.Randomized unconfounded trials comparing amphetamine with placebo.Two review authors independently selected trials for inclusion and assessed trial quality; one

2007 Cochrane

19. Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD

Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Article Text

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

20. Amphetamines for schizophrenia. (PubMed)

Amphetamines for schizophrenia. It is estimated that between 10% and 65% of people with schizophrenia use illicit drugs such as amphetamines. This group have an increased rate of hospitalisation, homelessness, unemployment and suicide compared with those with schizophrenia who do not abuse drugs.To evaluate the effects of amphetamines for people with schizophrenia in terms of clinically meaningful outcomes, cognitive functioning and physiological tests.We searched the Cochrane Schizophrenia (...) Group's Register (February 2002).We included all randomised controlled trials investigating the effects of amphetamines on people with schizophrenia, compared with a placebo intervention.Working independently, we selected and critically appraised studies, extracted data and analysed on an intention-to-treat basis. Where possible and appropriate we calculated risk ratios (RR) and their 95% confidence intervals (CI), with the number needed to treat (NNT). For continuous data we calculated Weighted Mean

2004 Cochrane